Other substances

Albireodelphin

An anthocyanidin glycoside.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Albireodelphin on PubChem

 

Structure image - Albireodelphin

C1=CC(=C(C=C1/C=C/C(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=CC4=[O+]C(=C(C=C34)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C6=CC(=C(C(=C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)O)O)O)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study
Spike protein 3CLpro RdRpol Small molecule In silico 		in silico 2.80

Predicted to bind the SARS-CoV-2 RNA-dependent RNA polymerase and spike protein.

 Oct/22/2020
Export (.csv)